---
$id: https://graph.org.ai/products/commodity/51141569
$type: Product
source: UNSPSC
code: "51141569"
title: "Nafimidone"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nafimidone

**UNSPSC Code**: 51141569
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticonvulsant agent with the molecular formula C15H12N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HZU3IQ1EWW, chemically known as 2-imidazol-1-yl-1-naphthalen-2-ylethanone but generally known as nafimidone, which bears US NIH Compound Identifier 51200. European Medicines Agency schedules nafimidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09122MIG. The term NAFIMIDONE is an International Non-Proprietary Name or INN. Most nations schedule nafimidone under HS 29332990 and SITC 51573. As of Q4 2014, NAFIMIDONE remains the US FDA Preferred Term for this commodity. SMILES: C1=CC=C2C=C(C=CC2=C1)C(=O)CN3C=CN=C3.

